Erythropoietin or darbepoetin for patients with cancer


Autoria(s): Tonia, Thomy; Mettler, Annette; Robert, Nadège; Schwarzer, Guido; Seidenfeld, Jerome; Weingart, Olaf; Hyde, Chris; Engert, Andreas; Bohlius, Julia
Data(s)

2012

Resumo

Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions.

Formato

application/pdf

Identificador

http://boris.unibe.ch/13941/1/Tonia%20CochraneDatabaseSystRev%202012.pdf

Tonia, Thomy; Mettler, Annette; Robert, Nadège; Schwarzer, Guido; Seidenfeld, Jerome; Weingart, Olaf; Hyde, Chris; Engert, Andreas; Bohlius, Julia (2012). Erythropoietin or darbepoetin for patients with cancer. Cochrane database of systematic reviews, 12(12), CD003407. Chichester: WileyInterscience 10.1002/14651858.CD003407.pub5 <http://dx.doi.org/10.1002/14651858.CD003407.pub5>

doi:10.7892/boris.13941

info:doi:10.1002/14651858.CD003407.pub5

info:pmid:23235597

urn:issn:1469-493X

Idioma(s)

eng

Publicador

WileyInterscience

Relação

http://boris.unibe.ch/13941/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Tonia, Thomy; Mettler, Annette; Robert, Nadège; Schwarzer, Guido; Seidenfeld, Jerome; Weingart, Olaf; Hyde, Chris; Engert, Andreas; Bohlius, Julia (2012). Erythropoietin or darbepoetin for patients with cancer. Cochrane database of systematic reviews, 12(12), CD003407. Chichester: WileyInterscience 10.1002/14651858.CD003407.pub5 <http://dx.doi.org/10.1002/14651858.CD003407.pub5>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

NonPeerReviewed